STELIS Biopharma commenced the construction of its customised, multi-product, biopharmaceutical manufacturing facility at Nusajaya in Johor. STELIS Biopharma and Bio-XCell had previously announced the signing of a build and lease agreement with Bio-XCell for the construction of the building and part of the equipment of the company´s 140,000 sq ft facility, for a total investment amount of $60 mn. The facility will incorporate ´next-gen´ single-use bio-processing technology with both mammalian and microbial manufacturing suites.
Contact: Stelis Biopharma.
Tel: 080-2780 5529. Fax: 080-6784 0800.